)
Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.
Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.
Pain and fever drug Paracetamol and blood-clot preventing Enoxaparin both post growth rates beyond 20%
Speaking to Business Standard, Samina Hamied, executive vice chairperson, Cipla, says one must invest in research and development (R&D) to feed the commercial growth engines
The Covid-19 portfolio contributed 5-6 per cent of Cipla's turnover during peak Covid waves, the firm said
Exact stake size not revealed, sources put the number at 70%
For the full fiscal, Cipla has posted a 4.7% jump in net profit to Rs 2,517 crore, revenue and Ebitda rose 13.6% and 6.4% respectively
Plant's OAI status is unchanged, hinting at status quo; Sun Pharma says will respond to observations within 15 days
CEPI has till date announced funding for nine such projects including the Bharat Biotech one
The National Technical Advisory Group on Immunisation (NTAGI) will hold its crucial meeting on vaccine for children next week
A Business Standard analysis found that most of the countries with an older cohort of population and higher in the development index had a lower excess mortality rate than India.
Obesity a growing concern, especially in urban India; marginal decline in stunting among children
The TFR ranges from 1.1 children per woman in Sikkim to 3 children per woman in Bihar
India's official Covid death toll is 481,486 between January 1, 2020, and December 31, 2021
Fewer women gave birth in institutional settings amid pandemic
At present, the firm has a capacity to make 1.5-2 billion Covid vaccines and 600 million non-Covid vaccines per annum.
Covid-19 deaths grew in 2021 compared to 2020
In the bulletin for April 18 and 25, INSACOG mentions that one case of coronavirus XE varient has been confirmed in the country.
One of the few to contain Omicron well, it has seen stronger peaks followed by declines
A senior government official had told Business Standard last week that so far there was no scientific evidence to expand the vaccination programme to young children
In a communication to all chief secretaries of states and UTs, Union Health secy Rajesh Bhushan has sought daily surveillance reports on illnesses shared with NCDC
A senior CDSCO official confirmed that there are plans to adopt the best practices used during the Covid-19 pandemic for non-Covid19 drugs too